DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 19 filers reported holding DEXCOM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $779,625 | +10.3% | 250,000 | 0.0% | 0.00% | – |
| Q1 2023 | $706,750 | +2.7% | 250,000 | 0.0% | 0.00% | – |
| Q4 2022 | $688,500 | +38.8% | 250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $496,000 | +7.8% | 250,000 | 0.0% | 0.00% | – |
| Q2 2022 | $460,000 | -97.9% | 250,000 | -97.0% | 0.00% | -100.0% |
| Q2 2021 | $21,447,000 | -57.3% | 8,253,000 | -63.8% | 0.01% | -61.5% |
| Q1 2021 | $50,195,000 | -45.0% | 22,777,000 | -43.2% | 0.01% | -51.9% |
| Q4 2020 | $91,206,000 | -18.2% | 40,115,000 | -9.1% | 0.03% | -28.9% |
| Q3 2020 | $111,534,000 | +1.8% | 44,150,000 | 0.0% | 0.04% | -2.6% |
| Q2 2020 | $109,522,000 | +23.8% | 44,150,000 | -12.7% | 0.04% | +5.4% |
| Q1 2020 | $88,439,000 | +15.6% | 50,590,000 | -2.1% | 0.04% | +54.2% |
| Q4 2019 | $76,534,000 | – | 51,670,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |